Adaptiv Capital
Adaptiv Capital is a company.
Active
Updated: ·
About
Adaptiv Capital is a company.
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Adaptiv Capital.
Adaptiv Capital is a company.
Adaptiv Capital is a company.
Key people at Adaptiv Capital.
Adaptive Capital Partners is a Singapore-based venture capital firm founded in 2022, focusing on early-stage investments in technology, health tech, and medtech companies across Southeast Asia.[3][4] Its mission centers on backing innovative startups in these sectors, with a track record of three investments, including a $3.5M Series A in Biorithm in December 2023.[3] The firm operates within the broader investment ecosystem, targeting high-growth opportunities in a region poised for tech expansion, though details on its full investment philosophy or startup ecosystem impact remain limited in available data.[4]
Note: Multiple entities share similar names, such as Adaptivv (a Swiss risk management firm for pension funds since 2016)[1], Adaptive Capital (a crypto hedge fund)[2], and Adaptive Capital Partners' financial advisory arm for middle-market companies[5]. This overview prioritizes the VC firm matching the query's "Adaptiv Capital" phrasing and investment context.[3][4]
Adaptive Capital Partners was established in 2022 in Singapore as an early-stage VC firm.[3] Limited public details exist on key partners or founders, but the firm quickly ramped up activity, completing its first noted investments by late 2022.[3] Its evolution has centered on Southeast Asia's tech and health sectors, aligning with regional growth in digital health and innovation post-pandemic.[4]
Adaptive Capital Partners rides the wave of Southeast Asia's tech boom, where health tech and medtech address aging populations, digital transformation, and post-COVID healthcare demands.[4] Timing is favorable amid rising VC interest in SEA (e.g., 2022-2023 funding surges), with market forces like government incentives in Singapore and Indonesia boosting startups.[3] The firm influences the ecosystem by funding early-stage innovators, potentially accelerating medtech adoption in a region with 670M+ people and expanding digital infrastructure.
Adaptive Capital Partners is poised for expansion as SEA's tech ecosystem matures, with trends like AI-driven health tech and regulatory easing shaping its pipeline.[4] Expect more Series A deals in medtech amid 2025's projected funding rebound; its influence could grow by building a concentrated portfolio of regional unicorns. This early-stage focus positions it to capture outsized returns in a high-potential market, echoing its nimble start since 2022.[3]
Key people at Adaptiv Capital.
